SLA Ventures is unique in we invest a much larger percentage of our own money into our syndicated deals (10% vs the standard 1-2%) and only syndicate deals where our investment is at least $25,000 (representing about 1/3 of all deals we invest in). This aligns our interests with our backers by:

Ensuring we have a substantial personal investment in our syndicated deals.
Ensuring we only syndicate deals for which we have the highest conviction.

We exercise discipline to our investment thesis which allows us to focus on companies with the following qualities:

Leadership teams with a proven track record of entrepreneurial success and grit.
Leadership teams incentivized heavily through stock, not through salary.
History of meeting or exceeding prior projections.
Focus on operational rigor and capital efficiency.
Scalable product that can thrive in a highly competitive market.

Shane Adams (Founder of SLA Ventures) - I am the Founder & CEO of Sagacious Consultants, a healthcare consulting firm, where we bootstrapped to 275 employees, operated in 40+ states and did over $50m in annual revenue until our acquisition in October, 2015 by the worlds largest consulting firm, Accenture (NYSE: ACN). Since, I've served as a Managing Director and advisor to ensure a smooth integration and a continuing of our existing vision.

Over the past four years, I've specialized and invested in 40+ startups in the B2B/B2C, SaaS, marketplaces and service based industries. My most notable exits have been:

FitMob - acquired by ClassPass
Ticketbis - acquired by eBay (NASDAQ: EBAY)
Filament Labs - acquired by athenahealth (NASDAQ: ATHN)
TurboAppeal - acquired by Paradigm Tax Group

Invest with SLĀ Ventures

6

0

Team

Investments